How to Measure Accelerated Underwriting ROI

Accelerated underwriting ROI measurement is one of those topics where the industry agrees it matters but nobody agrees on how to do it. Every carrier has a different mix of metrics. Some track cost per policy. Others fixate on cycle time. A handful are building mortality experience studies that won't produce meaningful data for another five years.

Which means many carriers running accelerated underwriting programs can't actually tell you whether the program is working. Not with the precision their CFO wants, anyway.

That's a problem, because the investments aren't small. Building or buying the data infrastructure, licensing prescription databases and electronic health records, training predictive models, redesigning application workflows. These programs often run into the tens of millions before a single policy gets auto-issued. The carriers that can demonstrate clear returns are the ones getting board approval for expansion.

Munich Re's retrospective study on electronic health record usage in accelerated underwriting found a net mortality saving of $971 per average policy, against an EHR data cost of roughly $55 per policy. That ratio—nearly 18:1 on protective value alone—is the kind of number that moves boardroom conversations.

The core metrics for accelerated underwriting ROI measurement

No single ROI number captures whether an accelerated underwriting program is performing. The economics spread across multiple dimensions, and each one tells a different part of the story.

Carriers that take measurement seriously track at least five categories: underwriting expense, cycle time, placement rate, mortality experience, and customer acquisition cost. Ignoring any one of them gives you an incomplete picture that can be misleading in either direction.

Underwriting expense per policy

This is the most straightforward metric and usually the first one carriers look at. Traditional fully underwritten policies involve paramedical exams ($80–$150 per exam), attending physician statements ($25–$75 per APS, plus weeks of wait time), and manual underwriter review time.

Accelerated programs replace some or all of those steps with electronic data pulls—prescription databases, motor vehicle records, credit-based insurance scores, and increasingly, electronic health records. The Society of Actuaries' research on simplified issue underwriting found that these approaches reduce underwriting expenses by more than 80% on the policies that qualify for acceleration.

But the per-policy savings depend heavily on how you account for the cost of cases that start on the accelerated path and then get kicked to traditional review. Those "fallout" cases actually cost more than if they'd gone through traditional underwriting from the start, because you've already paid for the electronic data pulls before adding the traditional process on top.

Cycle time and its downstream effects

Cycle time reduction is where the emotional case for accelerated underwriting lives. Going from 25–30 days to under a week is dramatic. Some carriers report decision times under 48 hours for policies that stay on the automated path. Damco Solutions reported that AI-driven underwriting systems at mature implementations have cut decision times to 12.4 minutes for standard policies.

But raw speed isn't the ROI metric. The ROI comes from what faster cycle times do to placement rates and not-taken rates. A policy that takes four weeks to issue gives the applicant four weeks to change their mind, find a cheaper option, or simply lose momentum. Speed reduces that leakage.

Placement rate impact

Placement rate—the percentage of submitted applications that actually result in an in-force policy—is probably the most financially meaningful metric and the hardest to attribute cleanly to the underwriting process.

Munich Re's industry survey on accelerated underwriting trends found a clear tradeoff: carriers with the lowest acceleration rates reported the highest placement rates, and carriers that accelerated more aggressively saw placement rates decline. This makes intuitive sense. Being more selective about which cases qualify for the fast path means those cases are more likely to close. But it also means fewer applicants get the speed benefit.

The question every carrier has to answer is where the optimal point on that curve sits for their product mix and distribution model.

Metric	Traditional underwriting	Accelerated underwriting	What to measure
Cost per policy	$150–$300+ (exam, APS, manual review)	$40–$80 (electronic data pulls)	Per-policy expense, including fallout reprocessing costs
Cycle time	20–35 days	2–7 days (automated path)	Median time to decision, not just best-case
Placement rate	65–75%	70–85% (varies by acceleration rate)	Change in placement rate vs. pre-program baseline
Not-taken rate	15–25%	8–15%	Reduction in policies offered but never placed
Mortality experience	Known (decades of data)	Uncertain (emerging data)	Actual-to-expected ratio, tracked by cohort year
Customer acquisition cost	Higher (longer funnel, more drop-off)	Lower (faster close, less leakage)	Total marketing + distribution cost per in-force policy

Where the real ROI hides: not-taken rate reduction

The not-taken rate gets less attention than it deserves. When an applicant qualifies for a policy but never follows through to issuance, the carrier has already spent money on underwriting, the agent has spent time on the sale, and the revenue never materializes. The SOA's research on simplified issue underwriting specifically identified not-taken rate reduction as one of the primary savings drivers—carriers reported that faster, less invasive processes kept applicants engaged through to policy delivery.

A carrier writing 100,000 policies annually with a 20% not-taken rate is losing the acquisition cost on 20,000 cases per year. If accelerated underwriting drops that to 12%, the math gets significant fast, especially when you factor in the lifetime value of those additional in-force policies.

This is the metric where digital health screening data, including contactless vitals assessment, adds a layer of value that pure data-pull approaches miss. When applicants can complete a health check from their phone in 30 seconds rather than scheduling a nurse visit two weeks out, the process feels less burdensome. Less burden means less abandonment.

Mortality experience: the metric that takes years

Here's the uncomfortable part. The most important long-term ROI metric for accelerated underwriting is mortality experience, and most programs haven't been running long enough to know.

The concern is adverse selection. If accelerated programs approve applicants who would have been rated or declined under traditional underwriting, the mortality on those policies will be worse than expected. Munich Re noted that over 70% of carriers expect accelerated underwriting mortality to be higher than pre-program mortality, yet the vast majority kept premium rates the same as fully underwritten rates. The thinking is that mortality differences can be partially offset by improved placement rates and expense savings.

RGA's analysis of accelerated underwriting points out that when digital health data provides information equivalent to what traditional exams and labs collect—with adequate recency—the protective value should be comparable. The key word is "should." The actual mortality data is still accumulating.

Carriers measuring this correctly are tracking actual-to-expected (A/E) mortality ratios by cohort, segmented by whether the policy was issued through the accelerated path or the traditional path. This comparison requires enough policy-years of exposure to be statistically credible, which usually means at least five to seven years of program operation.

Building a measurement framework that works

The carriers getting the clearest read on accelerated underwriting ROI tend to share a few characteristics in their measurement approach.

Establish a pre-program baseline

You can't measure improvement without knowing where you started. That baseline should include per-policy underwriting expense (broken down by component), median cycle time, placement rate by product and distribution channel, not-taken rate, and customer satisfaction scores if available.

Datos Insights (formerly Aite-Novarica Group) found that more than 80% of individual life insurers have implemented at least some level of automated underwriting, but many didn't capture detailed pre-program metrics, making ROI measurement after the fact much harder.

Segment by acceleration path

Not all policies in an accelerated program are actually accelerated. Many programs have eligibility criteria that only qualify 40–60% of applicants. Gen Re's Next Gen Underwriting Survey reported an average eligibility rate of about 59% across the companies that provided year-over-year data.

ROI metrics need to separate cases by path: fully accelerated (no human touch), partially accelerated (some automation but human review), and fallout to traditional (started accelerated, kicked to manual). Each path has different economics, and blending them together obscures the actual performance of the automated components.

Track the indirect revenue effects

The hardest but most valuable ROI component to capture is the revenue impact. Faster processes don't just save money on existing volume—they can grow volume. Agents sell more when they can promise faster decisions. Direct-to-consumer channels convert better when the experience is frictionless. And carriers with superior speed win more business from independent distribution networks that have multiple carrier options.

These effects are real, but pinning them precisely to the underwriting program versus other factors (marketing, pricing, product design) takes analytical rigor that most carriers are still developing.

Current Research and Evidence

The data on accelerated underwriting ROI is growing but still incomplete.

Munich Re's retrospective EHR study remains one of the most concrete data points. The $971 per-policy mortality saving against $55 in data costs demonstrates that the right electronic data sources provide real protective value at low marginal cost. But this measures one component—data cost versus mortality improvement—not total program ROI.

The SOA's 2020 research report on simplified issue underwriting documented expense reductions exceeding 80% for qualifying policies, primarily from eliminating lab tests and attending physician statements. While simplified issue and accelerated underwriting aren't identical, the expense dynamics overlap significantly for the automated components.

Send Technology's 2026 industry analysis observed that AI-driven automation investments are being held to stricter ROI thresholds than previous technology cycles, with carriers demanding measurable returns rather than accepting theoretical efficiency gains. This reflects an industry that has spent heavily on digital transformation and now needs proof that the spending worked.

The Future of Accelerated Underwriting ROI

The measurement challenge is going to evolve in two directions.

First, the mortality data will start maturing. Programs that launched in 2019 and 2020 are now approaching the five to seven year mark where cohort mortality starts becoming statistically meaningful. By 2028 or 2029, carriers will have their first credible answer to the adverse selection question. That data will reshape how the industry prices accelerated products and how aggressively carriers pursue automation.

Second, the data sources feeding accelerated programs are expanding. Electronic health records are becoming more accessible. Contactless health screening—where applicants capture vital signs through a smartphone camera—is adding a biometric data layer that wasn't previously available outside of traditional exams. Platforms like Circadify are developing these capabilities for insurers, creating new measurement dimensions around applicant engagement and completion rates.

The carriers that build measurement discipline now—tracking granular metrics across all five dimensions, segmenting by path, and establishing clear baselines—will be the ones best positioned to optimize their programs as the data matures.

Frequently Asked Questions

What is the most important metric for accelerated underwriting ROI?

There isn't a single most important metric. Cost per policy is easiest to measure, but placement rate impact often drives more financial value because it affects revenue rather than just expense. Long-term, mortality experience will determine whether the programs are sustainable. The carriers doing this well track all five dimensions—expense, speed, placement, mortality, and acquisition cost—together.

How long before mortality data becomes meaningful?

Most actuaries want at least five to seven years of policy-year exposure before drawing firm conclusions about mortality experience on accelerated cohorts. Programs that launched around 2019–2020 should start producing statistically credible data by 2027–2029, depending on volume and face amount distribution.

Do accelerated underwriting programs actually save money?

On a per-policy basis for cases that stay on the automated path, the savings are substantial—often 60–80% lower underwriting expense compared to traditional processes. But total program ROI depends on the acceleration rate, fallout rate, mortality experience, and volume effects. Some carriers have found that the technology investment and data licensing costs eat into per-policy savings during the first two to three years before scale kicks in.

How does digital health screening affect accelerated underwriting ROI?

Digital health screening reduces friction in the applicant experience, which directly impacts not-taken rates and placement rates. When applicants can complete a health assessment in seconds rather than scheduling a multi-week process, fewer drop out. The data also adds a biometric signal—real vital signs—that pure data-pull approaches (prescriptions, MVR, credit) don't capture, potentially improving risk selection quality and long-term mortality outcomes.